An asset management and biotechnology company

Cureteq is an asset management and biotechnology company developing innovative medicines based on a sophisticated artificial intelligence platform.

Cureteq leverages artificial intelligence to identify the optimal applications of a given molecule and to de-risk clinical development.

What we do

Cureteq is an asset management and biotechnology company developing innovative medicines based on a sophisticated artificial intelligence platform.

Cureteq leverages artificial intelligence to identify the optimal applications of a given molecule and to de-risk clinical development.

 

Cureteq est.
Nov 2021
Privately held

10+ Employees

Strategic partners
Innoplexus

Office in Zug

Portfolio company,
Oncoteq est. Apr 2022

Latest news

05 January 2024

Meeting at J.P. Morgan 2024?

Looking for partnering or investment with Cureteq or Oncoteq? CEO Mads Dalsgaard, CFO Swati Mehta, and CBO Sarah Holland will be attending so please reach out to set up meeting in San Francisco

27 November 2023

Oncoteq completes another in-licensing deal, adding a potential best-in-class CD30 antibody drug conjugate from Tubulis to its oncology pipeline 

OncoteqAG (Oncoteq), a clinical stage biotech company specializing in novel and innovative cancer treatments, is expanding its development pipeline by in-licensing the potential best-in-class antibody …

21 November 2023

Oncoteq further expands its pipeline, in-licensing a promising treatment for breast cancer 

Oncoteq, a clinical stage biotech company specializing in innovative cancer treatments, today announces its second in-licensing deal as it obtains a world-wide exclusive license to a novel compound wi …

Shortcuts

About Us

Cureteq combines asset management, biotechnology and artificial intelligence in a unique platform to drive assets efficiently and effectively to the next value inflection and beyond. Cureteq est. Nov …

Portfolio

The Cureteq portfolio currently comprises assets in two companies, Oncoteq, focusing on oncology, and a company still in stealth mode. Oncoteq

Platform

The Cureteq platform uniquely combines a fully flexible and agile biotech company-builder model with AI supported drug development

Transforming drug development

We aim to transform drug development and drive assets beyond value inflection points by:

  • Unlocking hidden value of unattended molecules through AI
  • Combining agility and expertise in a lean structure
  • Flexible partnering and financing model